Literature DB >> 12109854

Dual sampling of the endocervix and its impact on AutoCyte Prep endocervical adequacy.

Sarah J Day1, Eric L Deszo, Gregory G Freund.   

Abstract

We compared satisfactory for evaluation but limited by (limited by) and unsatisfactory gynecologic cytologic diagnoses for samples collected by conventional smearing with those generated with the AutoCyte Prep in a population with a historic squamous intraepithelial lesion (SIL) rate of less than 1%. Results from 18,819 AutoCyte Preps were compared with 53,835 conventional cervical smears. Furthermore, 23 women ages 18 to 65 years undergoing annual Papanicolaou tests underwent sequential sampling with the AutoCyte Prep and the Surgipath C-E brush. Comparison of the AutoCyte Prep with conventional cytologic diagnoses revealed the following: unsatisfactory rate, down 97%; limited by rate, down 67%; low-grade SIL rate, up 86%; cervical cancer rate, up 300%; and high-grade SIL rate, unchanged. Examination of unsatisfactory and limited by cases for the AutoCyte Prep showed that 88% were due to absence of endocervical cells (ECs). Dual sampling showed no improvement in EC recovery over the AutoCyte collection device. Compared with conventional Papanicolaou smears, the AutoCyte Prep significantly decreased the rate of unsatisfactory and limited by specimens while increasing low-grade SIL and cancer detection and EC recovery. The majority of limited by specimens with the AutoCyte Prep were due to absence of ECs, but use of a brush-type device for better endocervical sampling did not enhance EC recovery.

Entities:  

Mesh:

Year:  2002        PMID: 12109854     DOI: 10.1309/U72E-XD57-NF4J-XVG8

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Collection of the BD SurePath Pap Test with a broom device plus endocervical brush improves disease detection when compared to the broom device alone or the spatula plus endocervical brush combination.

Authors:  Sharon Davis-Devine; Sarah J Day; Amy Anderson; Ashley French; Darcy Madison-Henness; Naomi Mohar; Danielle Tansy; Adarsh Hiremath; Jeffrey A Douglas; Gregory G Freund
Journal:  Cytojournal       Date:  2008-02-12       Impact factor: 2.091

2.  Additional collection devices used in conjunction with the SurePath Liquid-Based Pap Test broom device do not enhance diagnostic utility.

Authors:  Sarah J Day; Darla L O'Shaughnessy; Jason C O'Connor; Gregory G Freund
Journal:  BMC Womens Health       Date:  2004-09-13       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.